Skip to main content

Novel Compounds Designed To Inhibit SARS-CoV-2 Main Protease

This shows the mpro inhibitorResearchers have developed two new compounds that are able to inhibit SARS-CoV-2 main protease. The study reports one of the compounds is a strong drug candidate for further investigative trials in the treatment of coronavirus.

from Neuroscience News https://ift.tt/2Kw8yMT
Labels:

Comments

Post a Comment

Popular posts from this blog

More Evidence that Patient Portals Improve Patient Care

Of all the medical specialties, neurologists see some of the most complex patients. This idea bears out anecdotally among the neurologists we have interviewed here at Neurology Insights but also statistically. In this 2018 study published in JAMA , neurologists were ranked #3 among physician types for patient complexity as well as for their number of comorbidities (Nephrologists were ranked #1, if you must know). Not surprisingly, among the comorbidities they listed: diabetes . In addition to the neurological sequelae associated with diabetes, this complex and chronic condition often requires well-coordinated care involving repeated testing and care by other providers. A new study published last month (June, 2019) in the journal PlosOne , shows that all this can be improved when these complex patients have access to a patient portal . “A patient portal is a secure online website that gives patients convenient, 24-hour access to personal health information from anywhere with an Inte...
Post a Comment
Read more